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1. Introduction
Cardiomyopathy is a heterogeneous group of disorders of varying etiology. Heart failure from
systolic and/or diastolic cardiac dysfunction is common to all. Certain disorders are distin‐
guished by life threatening arrhythmia. Onset of symptoms may be acute or progress from
preclinical to symptomatic state over time and at a variable rate. Early recognition permits
therapeutic intervention thereby retarding clinical progression and in some reversal or arrest
of pathologic state. Echocardiography being the most frequently used and readily available
cardiac imaging technique has established itself as the cardiac imaging modality of choice in
diagnosis and longitudinal follow up of patients with cardiomyopathy. Complementary
information from other imaging techniques, e.g., tissue characterization with cardiac MRI in
iron overload states and evaluation of coronary anatomy with cardiac CT as in some cases of
dilated cardiomyopathy, usually follows recognition of cardiomyopathy on echocardiogram.
An understanding of conventional echocardiogram and knowledge of novel applications of
existing methods and emerging imaging echo techniques is important for effective clinical use
of echocardiography.
1.1. Standard 2-D and M-mode echocardiogram
Standard echocardiogram includes analysis of myocardial and valvular structure, chamber
quantification and estimation of function based on qualitative assessment and quantification
by 2-D and M-mode echocardiography. Blood flow dynamics through different cardiac
chambers and heart valves is assessed using spectral and color Doppler methods. Through
prior work, pressure gradient across heart valves can be derived from measured flow velocity
by using the modified Bernoulli equation (4V2); flow velocity is directly measured from
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spectral Doppler display. Color Doppler techniques are useful in analyzing regurgitant valve
lesions and in drawing attention to turbulent flow through stenotic valves as well as abnormal
flow between cardiac chambers as in cases of atrial or ventricular septal defect.
1.2. Three Dimensional Echocardiography (3DE)
In patients with adequate imaging window, 3DE provides more accurate chamber quantifi‐
cation (Figure-1). Left ventricular end-diastolic and end-systolic volumes derived from 3DE
has been validated against cardiac MRI [1], which is the current reference standard for such
measurements. In routine clinical practice important use of 3DE derived chamber quantifica‐
tion is in establishing an accurate baseline, and in longitudinal follow up of patients. In addition
to chamber quantification and determination of global left ventricular function, automated
quantification also permits contractile assessment at regional and segmental level. The
graphical display of this contractile information is plotted as segmental change in volume over
time. Discrepant timing of this segmental volume change over time has been used to assess
left ventricular dyssynchrony as that seen in patients with left bundle branch block (LBBB)
pattern on ECG (Figure-1). However, concerns with reproducibility in patients with low left
ventricular ejection fraction have compromised the diagnostic utility of this parameter in
selecting patients for cardiac resynchronization therapy [2].
Figure 1. Panel-A: 3D data set of the heart is automatically cropped to display a 4-chamber and 2-chamber (not
shown) projection of the heart. Left ventricular volume is tracked in end-diastole and end-systole from which volumet‐
ric LVEF is calculated. In panel-C segmental model of the heart is displayed. Each segment is color coded. Graphical
display of the volume (y-axis) change over time (x-axis) is shown in panels-B and D. Each colored line corresponds to a
segment of similar color in panel-C. In a normal heart all segments reach a minimum volume at the same time (panel-
B). In panel-D there is a disarray of this time-volume curve signifying left ventricular dyssynchrony.
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1.3. Doppler tissue velocity and doppler strain
Modification of the spectral tissue Doppler technique with filters that display high amplitude
and low velocity signal permits segmental interrogation of myocardium for both systolic and
diastolic function. Tissue Doppler at the mitral annulus level has long been used to assess
myocardial diastolic function. Reversal of high early diastolic velocity (E’) with diastolic
velocity coinciding with atrial systole (A’) is a flow independent marker of diastolic impair‐
ment. An elevated ratio of early mitral inflow Doppler velocity (E) with early tissue Doppler
velocity (E’) is considered a reliable sign of elevated left ventricular end diastolic pressure [3-4].
Color encoded display of myocardial velocities on a 2-D image of the LV permits parametric
assessment of myocardial contraction and Doppler based interrogation of multiple myocardial
segments in the same frame. The latter is used for estimation of myocardial velocity and strain
(Figure-2). Myocardial velocity in the long axis determines myocardial displacement, which
may be active contraction or passive motion from contraction of adjacent segments [5]. Hence,
its usefulness is limited when assessing segmental function. On the other hand, Doppler-
derived longitudinal and circumferential strain measures segmental myocardial lengthening
or shortening (deformation), signifying active contraction of the interrogated segment [5].
Strain is a dimensionless index (change in length/original length) of myocardial mechanics.
The technique has been used for determination of cardiomyopathy in hereditary conditions,
Figure 2. Color tissue Doppler derived tissue velocity (panel-A) and longitudinal strain (panel-B) is shown. Basal infero‐
septum and lateral walls are interrogated. Panel-A: time (x-axis) to peak systolic tissue velocity (y-axis) measured from
the onset of QRS (ECG displayed at the bottom of each panel in green color) of inferoseptum (red) is delayed when
compared to the lateral wall (yellow). This signifies dyssynchrony. Longitudinal strain is shown in panel-B. Inferosep‐
tum timing is again delayed. Note, however, that peak strain (strain is a negative value when measured in the long
axis of the heart due to compression/shortening of the interrogated segment in systole) of inferoseptum is decreased
signifying contractile dysfunction.
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in differentiation of physiologic hypertrophy in elite athletes from pathologic variants [6, 23],
in assessment of myocardial dyssynchrony [7], and in differentiating constrictive from
restrictive physiology.
1.4. 2D or speckle strain and LV torsion
Doppler-based strain imaging is limited by angle dependency [8]. Innovation in imaging
hardware and software now permit tissue-based measurement of segmental, regional and
global myocardial function by determining tissue strain and torsion (Figure-3). The technique
relies on good 2-D image quality for tracking tissue characteristics, termed “speckles”, in
regions of interest on a 2-D image through the entire cardiac cycle. To improve spatial
resolution, image acquisition is performed at a slower frame rate contrasting with higher frame
rate of Doppler-based techniques [9]. This may influence the accuracy of time dependent
measurement of myocardial function as in milder forms of left ventricular dyssynchrony.
Potentially valuable clinical information can be derived from speckle strain in a variety of
cardiac disorders, including asymptomatic stages of cardiomyopathy [9].
Figure 3. Speckle strain measurement inlongitudinal and radial direction is performed.In Panel-A, longitudinal strain is
determinedat multiple levels from base to apex. Because contraction in longitudinal direction results in fiber shorten‐
ing, strain values are negative. Segmental impairment of longitudinalstrain or contractility is present. In panel-B radial
strain is depicted as a positive value due to fiber lengthening radially in systole. All segments at this level show normal
contractility.LV torsion can be determined from the same data set.
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Ratio of basal clockwise rotation to apical counterclockwise when viewed from the apex is
as a measure of left ventricle twist or torsion. It is produced by contraction of helically ori‐
ented myofibers. Left ventricle torsion is affected in both systolic and diastolic myocardial
dysfunction. When compared to a normal population, left ventricle torsion is decreased in
dilated cardiomyopathy and increased in patients with hypertrophic cardiomyopathy [10].
2. Echo findings in cardiomyopathies
For this review a modification of 1995 World Health Organization /International Society and
Federation of Cardiology (WHO/ISFC) Task Force on the Definition and Classification of
Cardiomyopathies [11] and 2006 American Heart Association classification of cardiomyo‐
pathic disorders [12] is used. Discussion on echocardiographic findings will be limited to more
frequently encountered disorders and to conditions with unique echo features.
2.1. Modified classification of primary and secondary cardiomyopathies
i. Genetic:
• Hypertrophic cardiomyopathy (HCM)
• Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D)
• Left ventricular non compaction (LVNC)
ii. Mixed (pre-dominantly non genetic):
• Dilated cardiomyopathy (DCM)
• Restrictive cardiomyopathy (non hypertrophied and non dilated) (RCM)
iii. Acquired Primary and Secondary Cardiomyopathy:
• Inflammatory myocarditis
• Stress provoked (takotsubo cardiomyopathy)
• Peripartum cardiomyopathy
• Tachycardia induced cardiomyopathy
• Ischemic cardiomyopathy
• Valvular cardiomyopathy
• Hypertensive cardiomyopathy
• Metabolic cardiomyopathy including amyloidosis and hemochromatosis
• Toxic cardiomyopathy: Alcohol and anthracyclines
• Connective Tissue Disorders: RA, SLE, PAN, scleroderma
Echocardiography Findings in Common Primary and Secondary Cardiomyopathies
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• Muscular dystrophies: Duchenne, Becker-type and myotonic dystrophy
• Neuromuscular disorder: Friedreich’s ataxia, Noonan’s syndrome and lentiginosis
3. Genetic cardiomyopathies
Echocardiography remains the cornerstone for the detection and longitudinal follow up of
patients with genetic cardiomyopathy. Inherited cardiomyopathies may have autosomal
dominant pattern of inheritance. As such, surveillance echocardiogram of asymptomatic
family members may allow early detection and life saving therapeutic intervention.
3.1. Hypertrophic Cardiomyopathy (HCM)
3.1.1. Introduction
HCM is the most frequently encountered inherited cardiomyopathy. Echocardiography plays
a central role in diagnosis of HCM and in elucidating the pathophysiology of this disorder.
3.1.2. Features of HCM on standard echocardiogram:
Key diagnostic features of HCM are apparent on standard echocardiogram and are described
below.
Distribution of left ventricular hypertrophy:
Several morphologic variants are known. Asymmetrical septal hypertrophy is the most
frequently encountered (Figure-4). Hypertrophy of more than one region of left ventricular
wall and at times of right ventricular wall is also seen. In the apical variant of HCM, myocardial
hypertrophy is confined to the apical region of the left ventricle. This type is more frequently
encountered in non-Caucasians.
Diagnostic criteria of Asymmetrical Septal Hypertrophy (ASH):
Septal thickness of >15 mm and a septal to posterior free wall ratio (interventricular septum/
posterior wall ratio) >1.3 are established echocardiographic criteria for the diagnosis of ASH
[12]. However asymmetric left ventricular hypertrophy by itself is not pathognomonic of HCM
as it may be encountered in a variety of congenital or acquired conditions, including systemic
hypertension, aortic stenosis and cardiac amyloidosis [14].
Left ventricular function:
Systolic function is usually normal or above normal. Despite preservation of global left
ventricular function [15], significant impairment of longitudinal contractile function is present
with attenuation of annular velocities, longitudinal strain and strain rate (see below) [16].
Progressive myocardial fibrosis in advanced disease state is associated with impairment of
systolic function, segmental myocardial thinning and left ventricle cavity enlargement [17].
Given myocardial characteristics, impaired myocardial relaxation is frequently observed [18].
Cardiomyopathies8
Echo methods of estimating left ventricular end-diastolic pressure (E/E’ ratio) show hetero‐
geneity and lack specificity in HCM [19].
Systolic Anterior Motion (SAM) of mitral valve:
Systolic anterior motion of the anterior mitral leaflet with or without obstruction to flow across
the left ventricular outflow tract is highly suggestive of HCM (Figure-4). This finding has a
specificity of > 90% [20]. Of note, SAM may also be encountered in hypercontractile states,
following mitral valve repair, with anomalous papillary muscle insertion, in patients with
anteroapical infarction, in takotsubo cardiomyopathy who have hyperkinesia of basal left
ventricular segment and in elderly women with left ventricular hypertrophy and sigmoid shaped
septum [21].
Figure 4. In panel A marked asymmetric septal hypertrophy (ASH) is noted (asterisk) in parasternal long axis display.
Systolic anterior motion (SAM) of the mitral valve is seen in panel B (arrow). Turbulence of blood flow through the left
ventricular outflow tract (LVOT) associated with posteriorly directed mitral regurgitation due to LVOT obstruction
from SAM is present (panel C). Spectral Doppler through the LVOT confirms LVOT obstruction with a late peaking gra‐
dient of 60 mmHg (panel D). In this example Valsalva maneuver was used to confirm dynamic LVOT obstruction.
Echocardiography Findings in Common Primary and Secondary Cardiomyopathies
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3.1.3. Tissue doppler imaging and speckle strain
Tissue Doppler and 2-D speckle techniques demonstrate impaired longitudinal velocity and
strain even in non-hypertrophied myocardial segments. These indices of longitudinal fiber
function are abnormal in inherited HCM even prior to grossly manifest left ventricular
hypertrophy. The degree of functional impairment by these measures correlates with clinical
outcome [22]. Furthermore, differentiation between pathologic and physiologic left ventricular
hypertrophy is possible by documenting preserved longitudinal function in the latter which
is impaired in HCM even when global left ventricular function is normal [23].
3.1.4. Three dimensional echo
A more accurate assessment of left ventricle mass and chamber volumes is made possible by
3DE. The clinical impact of this in routine clinical care is less apparent.
3.2. Arrhythmogenic right ventricular cardiomyopathy/dysplasia
3.2.1. Introduction
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a genetic cardiomy‐
opathy with autosomal dominant inheritance. However, phenotypes with cutaneous manifesta‐
tions have autosomal recessive inheritance. The disorder is pathologically characterized by
fibrofatty infiltration of the right ventricle (RV) wall. In early stages, dysplasia is localized,
affecting the RV inflow, RV outflow or RV apex. Progression to diffuse form is common. Clinical
manifestation is with ventricular arrhythmias and RV systolic dysfunction [24-25].
3.2.2. Echo diagnosis of ARVC/D
Morphological and functional changes affecting the RV are divided into major and minor
diagnostic  criteria.  In  the proposed revision of  ARVC/D task force document [26],  right
ventricle outflow tract (RVOT) long axis dimension of ≥ 32 mm (sensitivity/specificity: 75%
and 95%, respectively), RVOT short axis dimension of ≥ 36 mm (sensitivity/specificity: 62%
and 95%, respectively) and RV fractional area change of ≤33% (sensitivity/specificity: 55%
and 95%, respectively) are considered as major criteria for the diagnosis of ARVC/D. Minor
echo criteria are RVOT long axis dimension of ≥ 29 mm (sensitivity/specificity:  87% and
87%, respectively), RVOT short axis dimension of ≥ 32 mm (sensitivity/specificity: 80% and
80%, respectively) and RV fractional area change of ≤40% (sensitivity/specificity: 76% and
76%, respectively) [26].  Of interest,  diastolic dimensions of the RV taken from the apical
four-chamber view were least commonly enlarged [27]. Regional wall motion abnormali‐
ty  of  the  apex  and  anterior  wall  is  seen  in  approximately  70%  of  patients  [27].  Other
frequent  morphologic  abnormality  include  trabecular  derangement,  occurring  in  54%,
hyper-reflective  moderator  band  in  34%  and  sacculations  of  RV  free  wall  in  17%  [27].
Given its  predominant  autosomal  dominant  inheritance  screening of  family  members  is
recommended.
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3.3. Left ventricular non-compaction
3.3.1. Introduction
Left ventricular non-compaction (LVNC) is a distinct cardiomyopathy resulting from arrest of
fetal development of the heart [28]. This leads to altered myocardial architecture that is seen
as a two layered myocardium with a thin, compacted epicardial layer and a thick, non-
compacted endocardial region (Figure-5). The non-compacted myocardial region is comprised
of prominent trabeculations and deep intertrabecular recesses that directly communicate with
the left ventricular cavity [29-30].The condition may present without any associated cardiac
malformation and is then labeled isolated left ventricular non compaction (LVNC). Non
compacted myocardium is also seen in conjunction with other cardiac abnormalities including
cyanotic congenital heart disease, Ebstein’s anomaly and other cardiomyopathies. Clinical
presentation in LVNC is seen with congestive heart failure, ventricular arrhythmia and
systemic thromboembolism.
Figure 5. Marked trabeculation of LV myocardium is seen in the apical and inferolateral distribution (panel A) in this
off axis projection of apical long axis of the heart. Ratio of non comapcted to compacted myocardium is consistent
with the diagnosis of left ventricular non-compaction. Communication of deep intertrabecular recesses with LV cavity
is noted on color Doppler (panel B) and following administration of echo contrast (panel C). Visual appearance of the
non compacted myocardium is also enhanced following echo contrast.
3.3.2. Diagnostic criteria on cardiac imaging
Trabeculation in the left ventricle wall is seen even in healthy volunteers. To separate benign
left ventricular trabeculation from pathological LVNC following diagnostic criteria is pro‐
posed.
• Echocardiogram: ratio of non-compacted to compacted myocardium in end-systole of > 2:1
[31]
• Cardiac MRI: ratio of non-compacted to compacted myocardium in end-diastole of > 2.3:1
[32]
Echocardiography Findings in Common Primary and Secondary Cardiomyopathies
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The most frequently involved segments are apical, followed by the inferior and lateral mid-
segments. Severity and distribution of non compacted segment is better appreciated with use
of contrast echo.
Left ventricle contractile abnormality is present in patients with LVNC. The spectrum of
myocardial function may range from normal to severe systolic dysfunction. Documentation
of direct flow from ventricular cavity into inter-trabecular recesses either with color Doppler
technique or following use of echo contrast is helpful in differentiating LVNC from other apical
echocardiographic abnormalities such as apical hypertrophic cardiomyopathy and apical
mural thrombus [31]. Information from 3DE is also helpful in identifying the extent of LVNC
[33]. Screening of family members is advised.
4. Mixed genetic and non genetic cardiomyopathy
4.1. Dilated Cardiomyopathy (DCM)
4.1.1. Introduction
The prevalence of idiopathic dilated cardiomyopathy is not well understood but an estimate
in the USA is ∼40 per 100 000 persons [34]. DCM is the most common cardiomyopathy,
accounting for 60% of all primary cardiomyopathies [35] and is a leading cause of heart failure
and arrhythmia. Familial and sporadic forms of DCM are well described. Genetic factors are
important, with 20% of cases having a familial basis with an autosomal dominant inheritance
[36]. This has important implications for screening of first-degree relatives.
4.1.2. Features of DCM on standard echocardiogram
Wall motion abnormalities: Wall motion abnormality is global as opposed to regional
abnormalities in ischemic cardiomyopathy. However, some regional variation in myocardial
contractility may be encountered. Preservation of contractile function of basal inferolateral
segment is not infrequent. Due to these overlapping features, ischemic cardiomyopathy should
be conclusively excluded when appropriate.
Cardiac Chamber Enlargement: Left ventricular (LV) cavity enlargement and systolic
dysfunction in the absence of valvular or ischemic heart disease are key diagnostic features of
DCM. Dilatation of both left and right ventricles is encountered. Left ventricular cavity
assumes a spherical shape in advanced cases (Figure-6). Chamber quantification is preferred
over visual estimation for serial comparison. In addition to linear cavity dimension, which is
increased in DCM, calculation of left ventricle volume and systolic function derived from
modified biplane Simpson’s method is recommended.
Low Flow State: Consequent to sluggish blood flow velocity, patients are at risk of developing
LV mural thrombus. Low circulatory state can be appreciated by spontaneous echo contrast
in left ventricle and by an increase in separation of mitral valve E point to ventricular septum
and partial opening and early closure of aortic valve in systole. The latter is particularly
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important, as aortic stenosis may be overestimated on 2D echo (pseudo aortic stenosis) and
underestimated by Doppler (low-gradient aortic stenosis) due to low flow state. Contractile
augmentation with dobutamine is helpful in clarification in such situations [64].
Secondary Mitral Regurgitation: Altered mitral valve geometry from progressive LV cavity
enlargement will lead to mitral regurgitation, which may be severe in advanced cases [37].
Presence of mitral regurgitation predicts poor outcome [38].
Diastolic Dysfunction: Presence of diastolic abnormality is established by Doppler interrog‐
ation of mitral inflow and mitral annular velocities. Severity of diastolic abnormality may be
insightful and partly explanatory for the frequently observed discordance between degree of
LV systolic dysfunction and severity of clinical symptoms. Patients with earlier stage of
diastolic abnormality are less symptomatic when compared to those with more advanced
diastolic dysfunction. Reduction in effective diastolic filling period is reflected by fusion of
mitral diastolic E-wave and A-wave (Figure-6).
Figure 6. Apical four chamber view shows a dilated LV cavity with a spherical appearance. RV cavity is normal in this
example. Pulse-wave Doppler at mitral leaflet tip shows fusion of diastolic E and A waves. Latter is a reflection of re‐
duced diastolic filling period.
Right Ventricular (RV) Function: RV enlargement to a similar degree as the LV is associated
with poor outcome [39]. RV systolic function can be measured by fractional area change or by
tricuspid annular plane systolic excursion (TAPSE) [40]. TAPSE < 14 mm is associated with
Echocardiography Findings in Common Primary and Secondary Cardiomyopathies
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adverse prognosis [41]. In another study, 3DE derived measurement of RV volume and
function was superior to conventional method [42].
4.1.3. Novel echo techniques
Routine use of Doppler-derived strain and 2D strain may have limited application in clinically
manifest disease. Application of these techniques in preclinical state and in asymptomatic
family members with inherited type of DCM may identify at risk subset of patients. Observa‐
tion of intersegmental discordance in the timing of strain measures, particularly those of
opposing segments identify a subset of DCM patients with LV dyssynchrony, who may benefit
from cardiac resynchronization therapy.
4.2. Restrictive cardiomyopathy (non-hypertrophied and non-dilated)
4.2.1. Introduction
Primary restrictive cardiomyopathy (RCM) predominantly affects the elderly, with a slight
female predominance [43]. Clinical presentation is with signs and symptoms of systemic and
pulmonary venous congestion from diastolic heart failure and pulmonary HTN [43]. As
opposed to other types of primary cardiomyopathies which have distinctive morphologic
abnormalities, the diagnosis of RCM is largely dependent on an altered physiology of blood
flow through the heart consequent to a non compliant ventricle. The condition has no distinc‐
tive histologic features [44]. RCM should be distinguished from infiltrative disorders of the
heart where, in addition to restrictive physiology which may be indistinguishable from RCM,
distinctive morphologic and histopathologic changes are present. Amyloid heart disease and
endomyocardial fibrosis are typical examples of the latter.
4.2.2. Features of RCM on standard echocardiogram
Left ventricle (LV) appearance and contractility is usually normal. LV cavity size may be small.
Biatrial enlargement in the absence of significant regurgitation of mitral and tricuspid valves
or atrial fibrillation and with normal LV kinetics in patients with signs and symptoms of heart
failure should prompt consideration of RCM (Figure-7). Impaired diastolic relaxation of the
LV is encountered but a key diagnostic feature is the presence of restrictive physiology on
Doppler as evidenced by an increase in E:A ratio >2 with rapid deceleration of early mitral
inflow (E) velocity, usually to < 150 msec (Figure-7) [45]. This, in conjunction with reduced
early mitral annular velocity (E’) and elevated E/E’ ratio, is confirmatory of elevated left
ventricular end diastolic pressure (LVEDP). Reduced E’ velocity, reflecting underlying
myocardial disease, is useful in distinguishing RCM from constrictive pericarditis where
mitral annular velocities are preserved [46-47]. Deformation of the LV on 2D speckle strain is
constrained in the circumferential direction in constrictive pericarditis and in the longitudinal
direction in RCM [48]. Flow propagation velocity on color M-mode of mitral inflow can
provide additional insight into diastolic dysfunction of RCM.
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Figure 7. Morphologic and functional abnormality in restrictive cardiomyopathy is represented in this example. There
is biatrial enlargement on apical four chamber view (panel A). Restrictive diastolic filling abnormality (E: A ratio of > 2
with rapid deceleration of early mitral inflow velocity) by Doppler is noted (panel B).
5. Acquired primary and secondary cardiomyopathy
For the purpose of this review, discussion will be limited to key features of commonly
encountered acquired cardiomyopathy.
5.1. Inflammatory myocarditis
Inflammatory cardiomyopathy is defined by myocarditis in association with cardiac dysfunc‐
tion [11]. Idiopathic, autoimmune, and infectious forms of inflammatory cardiomyopathy are
recognized [11]. Echo findings are of non-specific LV cavity dilatation associated with global
LV dysfunction similar to that seen in idiopathic dilated cardiomyopathy. Regional variation
in LV contractility is not infrequently encountered.
5.2. Takotsubo cardiomyopathy (stress cardiomyopathy)
A transient and reversible cardiomyopathy first reported in Japan by Dote, et al., in 1991 [49].
Clinical presentation may be indistinguishable from acute coronary syndrome, invariably
necessitating coronary angiography for exclusion of obstructive coronary artery disease.
Prevalence is about 1-2% of patients undergoing coronary angiography for acute coronary
syndrome. A precipitating emotional or physical stressor is typical. Complimentary imaging
Echocardiography Findings in Common Primary and Secondary Cardiomyopathies
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modalities including echocardiography and cardiac MRI are helpful in diagnosis and in
monitoring clinical recovery. In fact, LV morphology at echocardiography is characteristic as
it resembles a takotsubo (Japanese octopus trap) with dilatation of the apical region of the heart
and preserved contractility of basal segments (Figure-8). About a fifth of patients will have
hyperdynamic contractility of basal LV segments with consequent left ventricular outflow tract
obstruction and systemic hypotension. Early recognition of this by echo has marked influence
on therapeutic choice [50]. Reverse pattern of LV contractile dysfunction has been described.
Right ventricular involvement in takotsubo is seen in 25-30% of patients and is associated with
a more complicated clinical course [51]. It is encountered in patients with more severe LV
involvement [52]. However, isolated right ventricular takotsubo has been reported [53]. The
condition is prone to formation of LV apical mural thrombus which should be carefully
excluded in all.
Figure 8. Diastolic and systolic frame of the LV in acute phase of takotsubo cardiomyopathy (panels A and B, respec‐
tively) and during recovery (panels C and D, respectively). Apical systolic expansion is noted during acute illness (panel
B). Apical endocardial border is highlighted in red. Normalization of apical systolic morphology and function is noted
upon recovery (panel D).
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5.3. PeriPartum Cardiomyopathy (PPCM)
The diagnosis of PPCM rests on the echocardiographic identification of new left ventricular
systolic dysfunction during a limited period surrounding childbirth. Other causes of cardio‐
myopathy should be excluded [54]. Features are typically that of dilated cardiomyopathy,
though LV cavity dimensions may be normal. Echocardiogram is used to monitor the effec‐
tiveness of treatment. In one study of PPCM recovery of LV function was reported in 54% of
study population [55]. This was more likely to happen in women with EF of > 30% at diagnosis
[55]. However, even in those with recovery of resting LV function by echo, contractile reserve
on dobutamine echo is reduced [56].The condition is likely to recur during subsequent
pregnancy even following recovery of LV function. The condition is associated with a worse
prognosis where recovery of LV function is incomplete or did not occur after the index
pregnancy [57]. Patients with LVEF of < 25% at diagnosis or in whom LV function has not
normalized should be counseled against subsequent pregnancy [58]. Early and serial echo‐
cardiogram may be considered during subsequent pregnancies in all patients with prior
history of PPCM.
5.4. Tachycardia Induced Cardiomyopathy (TIC)
There are no diagnostic features of TIC on echocardiogram. Non-specific dilated cardiomyop‐
athy may ensue from chronic tachyarrhythmia of either supraventricular or ventricular origin
[59-60]. Treatment of tachyarrhythmia is associated with recovery of LV systolic function, though
some degree of adverse LV remodeling may persist [61]. Diastolic dysfunction by echo is
encountered which may not reverse after normalization of LV systolic function [62].
5.5. Ischemic cardiomyopathy
On standard echocardiogram findings that constitute ischemic cardiomyopathy include
regional wall motion abnormalities, wall thinning with aneurysmal dilatation of the infarcted
myocardial segment, left ventricular (LV) cavity dilatation and decline in LV systolic per‐
formance that is out of proportion to the degree of underlying CAD (Figure-9).
Beyond recognition of an underlying ischemic process, an issue that frequently merits
clarification is that of hibernating viable myocardium and non-viable infarcted myocardium
[63]. This is particularly difficult to distinguish when infarcted myocardial segments have
normal or relatively normal thickness or when global LV contractile dysfunction as that seen
in DCM is encountered. For this low-dose dobutamine echocardiography test is useful.
Augmented contractility with dobutamine typically seen as a biphasic response is noted with
hibernating myocardium. Newer methods of assessing longitudinal fiber contraction during
dobutamine echo by long axis pulsed wave Doppler and M-mode is considered to be superior,
particularly in patients with LBBB [64].
5.6. Valvular cardiomyopathy
It is defined as ventricular dysfunction that is out of proportion to the abnormal loading
conditions of the heart [11]. Left ventricle is affected by regurgitant lesions of the mitral and
Echocardiography Findings in Common Primary and Secondary Cardiomyopathies
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aortic valves and by increased afterload of aortic stenosis. Primary valve abnormality can be
readily identified though findings can be blunted in the failing heart.
5.6.1. Aortic stenosis
Increased afterload of aortic stenosis results in concentric left ventricular (LV) hypertrophy.
LV cavity size is normal and systolic function preserved. With progressive disease LV
dilatation and impaired systolic function ensues. In patients with severe systolic dysfunction
assessment of aortic stenosis by Doppler can be challenging due to low flow velocity. Inotropic
augmentation of contractility and flow with dobutamine can be used in such cases [65].
Figure 9. Apical LV aneurysm (white arrow) is seen in a patient with ischemic cardiomyopathy. In another patient api‐
cal LV aneurysm is associated with a large LV mural thrombus (red arrow).
Cardiomyopathies18
5.6.2. Aortic regurgitation
LV cavity enlargement is present, which can be marked. Systolic function is initially preserved
but declines with advanced disease. Increase in LV end-diastolic pressure may blunt the color
Doppler signal of aortic regurgitation. Serial estimation of LV cavity dimension and volume
is necessary for aortic valve replacement prior to irreversible contractile dysfunction. LVEF of
≤ 50%, LV end-diastolic dimension of ≥ 70 mm and LV end-systolic dimension of ≥ 50 mm are
echo criteria for surgical intervention in asymptomatic individuals [66]. Abnormal longitudi‐
nal and circumferential strain is noted in the preclinical phase [67]. Incremental value of these
strain parameters for therapeutic intervention is not well established.
5.6.3. Mitral regurgitation
LV volume overload is well tolerated with preserved LV systolic function early in the disease.
Progressive decline in LV systolic function can be underestimated when using LV ejection
fraction as a marker of systolic performance. Left atrial enlargement is followed by LV cavity
enlargement. Progressive increase in left atrial pressure may decrease the color Doppler signal
of mitral regurgitation in advanced cases. LV end-systolic dimension of ≥ 45 mm or LVEF of
≤ 60% is used to time surgical intervention [68].
5.7. Hypertensive heart disease and cardiomyopathy
There is an increase in LV mass consequent to concentric hypertrophy of LV. Systolic function
is preserved. Variable degree of diastolic function is noted. In patients with severe LV
hypertrophy echocardiographic differentiation from other disease states with LV hypertrophy
is challenging. Restrictive filling pattern is seen in severe disease. Progressive disease is
associated with LV cavity dilatation and decline in LV systolic function similar to that seen in
dilated cardiomyopathy.
5.8. Metabolic cardiomyopathy
5.8.1. Amyloid heart disease
Cardiac amyloidosis is an infiltrative disorder of the heart which on echo is seen as thick-walled
left and right ventricles with normal left ventricular cavity dimension and systolic function.
Advanced disease is associated with decline in left ventricular systolic function. Increased
echogenicity from thickening of heart valves, biatrial enlargement and thickened interatrial
septum are other morphologic features of established disease. Pericardial effusion is seen in
more than half of patients [69] (Figure-10). Increased granular appearance of the heart in earlier
description of cardiac amyloidosis is not distinct on modern echo hardware and image
processing [70]. Assessment of transmitral flow and mitral annular velocities by Doppler
reveals impaired diastolic function. Restrictive diastolic filling pattern is noted in advanced
cases. Unlike in restrictive filling pattern, reduced mitral A- velocity may be seen with normal
mitral E-deceleration time. This finding suggests atrial myopathy and reduced contractility
from amyloid infiltration [71]. Some overlapping clinical and echocardiographic features of
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hypertrophic cardiomyopathy are seen in 5% of cases. In contrast to a hypertrophied ventricle,
low voltage in precordial leads is seen on ECG, and systolic anterior motion of mitral valve
which is a frequent observation in hypertrophic cardiomyopathy on echo, is uncommon in
patients with cardiac amyloidosis. By novel echo techniques longitudinal strain and strain rate
show systolic dysfunction despite preserved radial contraction as determined by fractional
shortening. The value of strain parameters in early diagnosis and in prognosis is being
evaluated [72]. Furthermore, strain measurement by 2D speckle tracking shows variation in
longitudinal strain from base to apex with relative preservation of apical strain. This finding
can be helpful in distinguishing cardiac amyloidosis from hypertrophic cardiomyopathy and
hypertrophy associated with increased afterload state of aortic stenosis [73].
Figure 10. Severe concentric left ventricular wall thickening and small pericardial effusion is present in this patient
with cardiac amyloidosis (panel A). Impaired mitral annular velocity is indicative of abnormal diastolic function (re‐
duced mitral annular velocities with reversal of E’ to A’ ratio) (panel B).
5.8.2. Hemochromatosis
There are no specific morphologic features on echocardiogram. Dilated cardiomyopathy is
seen in advanced stages of hemochromatosis [74]. Non-invasive diagnosis of cardiac involve‐
ment is dependent on demonstration of myocardial iron deposit on cardiac MRI [75]. In cases
with established cardiac involvement, assessment of myocardial kinetics by Doppler and tissue
strain may reveal functional impairment prior to development of overt cardiomyopathy. The
value of these new techniques in determining prognosis and in serial follow up of patients
following therapeutic intervention has been the subject of recent studies.
5.9. Toxic cardiomyopathy: Alcohol and anthracyclines
Echo findings are non-specific. Dilated cardiomyopathy from cardiotoxicity of alcohol cannot
be distinguished from idiopathic dilated cardiomyopathy. Impairment of left ventricle systolic
function is a concern for both anthracycline and some non-anthracycline based chemothera‐
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peutic regimens. Dose dependent cardiotoxicity from anthracyclines is reversible if detected
early and upon institution of effective heart failure therapy [76]. Serial assessment of left
ventricle systolic function, preferably by echo, is routine in such cases. Impaired tissue kinetics
by measures of myocardial strain and strain rate is noted prior to gross impairment of left
ventricle systolic function. This may have a role in influencing management [77].
6. Conclusion
Value of echocardiography in the diagnosis, prognosis and monitoring of therapy in patients
with cardiomyopathy is discussed in the preceding review. 3DE, Doppler and speckle strain
and left ventricular torsion may have a role in preclinical disease states. Incorporation of these
diagnostic methods in routine clinical assessment of patients with cardiomyopathy is depend‐
ent on emerging data on the usefulness and reproducibility of these techniques.
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